Nuwellis (NUWE) Gross Margin (2016 - 2026)
Nuwellis' (NUWE) quarterly Gross Margin came in at 76.08% in Q2 2026, up 2054.0% on a YoY basis from 3.53% in Q2 2025, and up 8.56% quarter-over-quarter from 70.08% in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Gross Margin (2016 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Gross Margin for 11 consecutive years, with 76.08% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 2054.0% year-over-year to 76.08%; the trailing twelve-month figure through Jun 2026 stood at 69.69% (up 914.0% YoY), and the FY2025 full-year result was 61.96%, down 298.0% from the prior year.
- Gross Margin climbed to 76.08% in Q2 2026 per NUWE's latest filing, from 70.08% in the prior quarter.
- Across five years, Gross Margin topped out at 76.08% in Q2 2026 and bottomed at 48.03% in Q2 2022.
- Historically, Gross Margin has averaged 61.07% across 5 years, with a median of 58.39% in 2023.
- The sharpest annual moves came in 2022 and 2026: Gross Margin plunged 1221 bps in 2022, then surged 2054 bps in 2026.
- Over 5 years, Gross Margin stood at 56.9% in 2022, then dropped by 4 bps to 54.41% in 2023, then gained by 7 bps to 58.35% in 2024, then gained by 17 bps to 68.23% in 2025, then rose by 11 bps to 76.08% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 76.08%, 70.08%, and 68.23% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 76.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.08% |
| Mar 31, 2026 | 70.08% |
| Dec 31, 2025 | 68.23% |
| Sep 30, 2025 | 65.18% |
| Jun 30, 2025 | 55.54% |
| Mar 31, 2025 | 56.04% |
| Dec 31, 2024 | 58.35% |
| Sep 30, 2024 | 69.96% |
| Jun 30, 2024 | 67.18% |
| Mar 31, 2024 | 64.14% |
| Dec 31, 2023 | 54.41% |
| Sep 30, 2023 | 57.26% |
| Jun 30, 2023 | 55.28% |
| Mar 31, 2023 | 58.43% |
| Dec 31, 2022 | 56.90% |
| Sep 30, 2022 | 60.97% |
| Jun 30, 2022 | 48.03% |
| Mar 31, 2022 | 57.22% |
| Dec 31, 2021 | 54.45% |
| Sep 30, 2021 | 60.44% |